ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 43 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $87,000 | +38.1% | 83,826 | 0.0% | 0.00% | – |
| Q4 2018 | $63,000 | -64.6% | 83,826 | 0.0% | 0.00% | – |
| Q3 2018 | $178,000 | -9.6% | 83,826 | -1.6% | 0.00% | – |
| Q2 2018 | $197,000 | -57.8% | 85,229 | -42.0% | 0.00% | – |
| Q1 2018 | $467,000 | -25.6% | 146,878 | -4.1% | 0.00% | – |
| Q4 2017 | $628,000 | -9.1% | 153,196 | +0.2% | 0.00% | – |
| Q3 2017 | $691,000 | +30.9% | 152,885 | -3.6% | 0.00% | – |
| Q2 2017 | $528,000 | -63.4% | 158,578 | +1.3% | 0.00% | – |
| Q1 2017 | $1,442,000 | +32.9% | 156,596 | +11.3% | 0.00% | – |
| Q4 2016 | $1,085,000 | -29.6% | 140,746 | +4.3% | 0.00% | – |
| Q3 2016 | $1,542,000 | -7.7% | 134,904 | -0.7% | 0.00% | – |
| Q2 2016 | $1,671,000 | +23.7% | 135,804 | +1.6% | 0.00% | – |
| Q1 2016 | $1,351,000 | -57.2% | 133,653 | -4.6% | 0.00% | -100.0% |
| Q4 2015 | $3,159,000 | +44.5% | 140,145 | +6.3% | 0.00% | 0.0% |
| Q3 2015 | $2,186,000 | -21.7% | 131,840 | +6.3% | 0.00% | 0.0% |
| Q2 2015 | $2,791,000 | +14.9% | 124,073 | +31.7% | 0.00% | 0.0% |
| Q1 2015 | $2,429,000 | +19.9% | 94,217 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $2,026,000 | +14.7% | 93,126 | -0.2% | 0.00% | 0.0% |
| Q3 2014 | $1,766,000 | -19.0% | 93,301 | -0.3% | 0.00% | 0.0% |
| Q2 2014 | $2,180,000 | -30.5% | 93,543 | +0.4% | 0.00% | 0.0% |
| Q1 2014 | $3,136,000 | +2257.9% | 93,172 | +1975.1% | 0.00% | – |
| Q4 2013 | $133,000 | – | 4,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|